Article info

Download PDFPDF
Nanotechnology based therapeutics for lung disease

Authors

  • Mohammad Doroudian Department of Medicine, Tallaght University Hospital, Dublin 24 & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Ronan MacLoughlin Aerogen, IDA Business Park, Galway, Ireland School of Pharmacy, Royal College of Surgeons, Dublin, Ireland School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Fergus Poynton Department of Medicine, Tallaght University Hospital, Dublin 24 & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Adriele Prina-Mello CRANN Institute and AMBER Centre, University of Dublin Trinity College, Dublin, Ireland Department of Medicine, Laboratory for Biological Characterization of Advanced Materials (LBCAM), Trinity College Dublin, Dublin, Ireland Nanomedicine Group, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  • Seamas C Donnelly Department of Medicine, Tallaght University Hospital, Dublin 24 & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland PubMed articlesGoogle scholar articles
  1. Correspondence to Seamas C Donnelly, Department of Medicine, Trinity Centre, Tallaght University Hospital, Dublin 24, Dublin, Ireland; seamas.donnelly{at}tcd.ie
View Full Text

Citation

Doroudian M, MacLoughlin R, Poynton F, et al
Nanotechnology based therapeutics for lung disease

Publication history

  • Received January 2, 2019
  • Revised May 6, 2019
  • Accepted May 13, 2019
  • First published July 8, 2019.
Online issue publication 
September 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.